article thumbnail

In-Home Daycare vs. Licensed Facility – A Working Mom’s Perspective

Perficient: Drug Development

While it proved to be tricky to find an opening for an infant, we endeavored to compare in-home daycares and licensed facilities. Through this blog, I aim to offer insights based on our personal experience, hoping to assist new parents in making informed choices that were not apparent to me when we welcomed our first child to the family.

article thumbnail

CDD Includes Industry-Leading IUPAC Naming Technologies From iChemLabs Directly Within CDD Vault

Collaborative Drug

This integration is facilitated through the licensing of the ChemDoodle Java Application Programming Interface (API), enhancing CDD Vault’s capabilities in cheminformatics and chemical structure analysis.

Licensing 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PIMICOTINIB

New Drug Approvals

History In December 2023, Abbisko Therapeutics entered into a licensing agreement for pimicotinib in all indications for China rights with Merck KGaA. [2] 2023) [link] ^ “Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck” [link] (Press release). 6] The U.S. .

article thumbnail

Expanded Access to Rabies Plasmids

addgene Blog

Addgene is excited to announce we now offer an export license application for rabies materials! The export license, if granted, allows us to ship rabies plasmids and viral vectors containing genetic elements from rabies plasmids to international requestors. We also offer export license applications for VSV and SARS-COV-1 plasmids.

Licensing 104
article thumbnail

k kh,h,,h, jjgm gmm

Twist Bioscience

Learn More > Variant Libraries Order Now TCR Libraries New Combinatorial Variant Library Spread Out Low Diversity Libraries Site Saturation Libraries Enzyme Screening Kits New Watch how Twist builds variant libraries for your perfect application Synthetic Controls Order Now Liquid Biopsy cfDNA Pan-Cancer Reference Standards v2 New Infectious Disease (..)

RNA 52
article thumbnail

Hyman, Phelps & McNamara, P.C. (HP&M) is Pleased to Announce the Addition of Sara M. Keup as the new State Licensing Regulatory Expert for the Firm’s Licensing Practice

FDA Law Blog: Biosimilars

HP&M has been helping clients navigate the challenges of state licensing regulations for drugs, biologics, medical devices, OTCs, 503B outsourcing facilities, 503A pharmacies, foods, dietary supplements, cannabis, and wholesalers/distributors for many years. Keup has joined the firm to assist attorneys Karla L.

article thumbnail

What to Expect When you are Expecting…a Government Shutdown

FDA Law Blog: Biosimilars

For pre-license or pre-approval inspections, the outcome of a shutdown is less draconian as these are under the auspices of a user-fee program. If the shutdown were to occur on Monday March 3 rd , inspectors may be recalled from active or on-going inspections to be placed on furlough.